Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (odpre novo okno)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Vir‎: Crit Care Med 2009;37(4):1299-307.

Indeksirano‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (odpre novo okno)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (odpre novo okno)

Ball AM, Winstead PS.

Vir‎: Pharmacotherapy 2008;28(11):1383-90.

Indeksirano‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (odpre novo okno)

Reducing postburn injury anemia in a Jehovah's Witness patient. (odpre novo okno)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Vir‎: J Burn Care Res 2014;35(4):e258-61.

Indeksirano‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (odpre novo okno)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (odpre novo okno)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Vir‎: Clin Ther 2008;30(12):2324-34.

Indeksirano‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (odpre novo okno)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (odpre novo okno)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Vir‎: Transplant Proc 2015;47(8):2548-51.

Indeksirano‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (odpre novo okno)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (odpre novo okno)

Charles A, Purtill M, Napolitano LM.

Vir‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeksirano‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (odpre novo okno)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (odpre novo okno)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Vir‎: Crit Care Med 1999;27(11):2346-50.

Indeksirano‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (odpre novo okno)

Erythropoietin for critically ill trauma patients: a missed opportunity? (odpre novo okno)

Corwin HL, Napolitano LM

Vir‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indeksirano‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (odpre novo okno)

Postoperative management of severe acute anemia in a Jehovah's Witness. (odpre novo okno)

de Araújo Azi LM, Lopes FM, Garcia LV

Vir‎: Transfusion 2014;54(4):1153-7.

Indeksirano‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (odpre novo okno)

Restrictive transfusion in geriatric trauma patients. (odpre novo okno)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Vir‎: Am Surg 2016;82(1):85-8.

Indeksirano‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (odpre novo okno)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (odpre novo okno)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Vir‎: J Trauma 1998;44(2):361-7.

Indeksirano‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (odpre novo okno)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (odpre novo okno)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Vir‎: Crit Care 2005;9(5):R508-15.

Indeksirano‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (odpre novo okno)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (odpre novo okno)

Hong T, Shander A, Agarwal S, Castresana M.

Vir‎: A A Case Rep 2015;4(10):127-31.

Indeksirano‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (odpre novo okno)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (odpre novo okno)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Vir‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indeksirano‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (odpre novo okno)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (odpre novo okno)

Lindholm J, Palmér K, Frenckner B.

Vir‎: Perfusion 2012;27(4):332-4.

Indeksirano‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (odpre novo okno)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (odpre novo okno)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Vir‎: Am Surg 2010;76(9):951-6.

Indeksirano‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (odpre novo okno)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (odpre novo okno)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Vir‎: Intensive Care Med 2013;39(11):1896-908.

Indeksirano‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (odpre novo okno)

Transfusion-free treatment strategies for acute anemia in critical care. (odpre novo okno)

Morgan CA, Byul Sarah S, Forest CP.

Vir‎: JAAPA 2016;29(8):38-44.

Indeksirano‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (odpre novo okno)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (odpre novo okno)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Vir‎: J Trauma 2008;65(2):285-97.

Indeksirano‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (odpre novo okno)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (odpre novo okno)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Vir‎: J Trauma 2009;67(1):121-4.

Indeksirano‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (odpre novo okno)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (odpre novo okno)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Vir‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indeksirano‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (odpre novo okno)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (odpre novo okno)

Posluszny JA Jr, Napolitano LM.

Vir‎: Transfusion 2014;54(12):3026-34.

Indeksirano‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (odpre novo okno)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (odpre novo okno)

Price S, Pepper JR, Jaggar SI.

Vir‎: Anesth Analg 2005;101(2):325-7.

Indeksirano‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (odpre novo okno)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (odpre novo okno)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Vir‎: Am Surg 2015;81(6):e263-5.

Indeksirano‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (odpre novo okno)

Erythropoietin response is blunted in critically ill patients. (odpre novo okno)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Vir‎: Intensive Care Med 1997;23(2):159-62.

Indeksirano‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (odpre novo okno)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (odpre novo okno)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Vir‎: Br J Anaesth 2005;94(4):442-4.

Indeksirano‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (odpre novo okno)

Management of anemia in patients who decline blood transfusion. (odpre novo okno)

Shander A, Goodnough LT

Vir‎: Am J Hematol 2018;93(9):1183-91.

Indeksirano‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (odpre novo okno)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (odpre novo okno)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Vir‎: Arch Surg 2012;147(3):251-5.

Indeksirano‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (odpre novo okno)

Intravenous iron following cardiac surgery does not increase the infection rate. (odpre novo okno)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Vir‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indeksirano‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (odpre novo okno)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (odpre novo okno)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Vir‎: Crit Care 2015;19:49.

Indeksirano‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (odpre novo okno)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (odpre novo okno)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Vir‎: Crit Care Med 2024;52(4):618-25.

Indeksirano‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (odpre novo okno)